CEA and CA 15.3 serum concentrations in patients with primary... | Download Table
The CA 15-3 test and breast cancer: What it is and results
Preoperative CA 15-3 and CEA serum levels as predictor for breast cancer outcomes - ScienceDirect
Tumor markers in metastatic breast cancer subtypes: frequency of elevation and correlation with outcome - ScienceDirect
Predictive markers for pathological complete response after neo-adjuvant chemotherapy in triple-negative breast cancer - ScienceDirect
Tumor markers in metastatic breast cancer subtypes: frequency of elevation and correlation with outcome - ScienceDirect
Prognostic value of monitoring tumour markers CA 15-3 and CEA during fulvestrant treatment | BMC Cancer | Full Text
M1 macrophages evoke an increase in polymeric immunoglobulin receptor (PIGR) expression in MDA-MB468 breast cancer cells through secretion of interleukin-1β | Scientific Reports
Axillary Lymph Node Metastasis: CA-15-3 and Carcinoembryonic Antigen Concentrations in Fine-Needle Aspirates for Preoperative Diagnosis in Patients with Breast Cancer | Radiology
![PDF] Analysis of tumour marker CA 15-3 in breast cancer following surgery | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/4744f482e3401b93bffb69ba515294512d87cb8d/2-Table1-1.png "PDF] Analysis of tumour marker CA 15-3 in breast cancer following surgery | Semantic Scholar")
PDF] Analysis of tumour marker CA 15-3 in breast cancer following surgery | Semantic Scholar
Relationship between CA 15-3 serum levels and size of the tumor in the... | Download Scientific Diagram
Elucidating tumor heterogeneity from spatially resolved transcriptomics data by multi-view graph collaborative learning | Nature Communications
The prognostic significance of preoperative tumor marker (CEA, CA15-3) elevation in breast cancer patients: data from the Korean Breast Cancer Society Registry | SpringerLink
Tumor markers in metastatic breast cancer subtypes: frequency of elevation and correlation with outcome - ScienceDirect
Elevated Levels of Serum Tumor Markers CEA and CA15-3 Are Prognostic Parameters for Different Molecular Subtypes of Breast Cancer | PLOS ONE
Elevation of serum CEA and CA15‑3 levels during antitumor therapy predicts poor therapeutic response in advanced breast cancer patients
Plasma levels of tested cytokines and CA 15-3 in patients with breast... | Download Table
Dual Mechanisms of LYN Kinase Dysregulation Drive Aggressive Behavior in Breast Cancer Cells
Relationship between preoperative serum markers CA 15-3 and CEA and relapse of the disease in elderly (>65 years) women with breast cancer. | Semantic Scholar
Tumor Marker Tests for Breast Cancer
Dual Mechanisms of LYN Kinase Dysregulation Drive Aggressive Behavior in Breast Cancer Cells - ScienceDirect
Tumor Markers for Breast Cancer: Benefits, Drawbacks, Results & More
Table 2 from Evaluation of tumor markers in southern Indian breast cancer patients. | Semantic Scholar
Tumor markers in metastatic breast cancer subtypes: frequency of elevation and correlation with outcome - ScienceDirect
An individual reference limit of the serum CEA-TPA-CA 15-3 tumor marke | CMAR
